1-2 of 2
Stellanie Krimm
Close
Sort by
Journal Articles

CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, SΤRO-001

Millicent Embry, Xiaofan Li, PhD, Abigail Yu, PhD, Cristina Abrahams, PhD, Nancy Y. Greenland, MD PhD, Kwun Wah Wen, MD PhD, Chris Jones, Venita DeAlmeida, PhD, Stellanie Krimm, Sarah Krueger, PhD, Shannon Matheny, PhD, Toni Kline, PhD, Alice Yam, PhD, Ryan Stafford, PhD, Arun P. Wiita, MD PhD, Trevor Hallam, PhD, Mark Lupher, PhD, Arturo Molina, MDMS, FACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 4420.
https://doi.org/10.1182/blood.V130.Suppl_1.4420.4420
Published: 2017
Journal Articles

Discovery and Preclinical Development of Novel CD74-Targeting Antibody-Drug Conjugates (ADCs) with Significant Activity in Multiple Myeloma (MM) Cell Lines and Xenograft Models

Cristina Abrahams, PhD, Xiaofan Li, PhD, Abigail Yu, PhD, Stellanie Krimm, Jason Kahana, PhD, Rama Krishna Narla, PhD, Eric Schwartz, PhD, John Boylan, PhD, Heidi Hoffmann, PhD, Alexander Steiner, M.S., James Zawada, PhD, Heather Stephenson, Maureen Bruhns, PhD, Venita DeAlmeida, PhD, Shannon Matheny, PhD, Stuart Bussell, PhD, Adam Galan, PhD, Toni Kline, PhD, Nicki Vasquez, PhD, Alice Yam, PhD, Ryan Stafford, PhD, Henry Heinsohn, Aaron Sato, PhD, Arturo Molina, MD MS, Trevor Hallam, PhD, Mark Lupher, Jr., PhD
Journal: Blood
Blood (2016) 128 (22): 4465.
https://doi.org/10.1182/blood.V128.22.4465.4465
Published: 2016